Neoadjuvant carboplatin/taxane (CbT) with or without doxorubicin/cyclophosphamide (AC) in real-world patients with early triple negative breast cancer (TNBC).
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Mary C. Schroeder, Brahmendra Reddy Viyyuri, Dana McDougall, Sneha Deepak Phadke, John A. Charlson, Noel Estrada-Merly, Cole G. Chapman, Joan Marie Neuner
Institutions: University of Iowa, Medical College of Wisconsin
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4410816819